Tempus AI
Research Tempus AI (F3M) on Bullrun: market cap EUR 10.84B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerF3M
- ExchangeF
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 10.84B
- Financial periodQ2 2026
- RevenueUSD 382.49M
- Net incomeUSD 5.64M
- Free cash flow-USD 18.62M
- Gross margin64.4%
Valuation Snapshot
latest market cap is EUR 10.84B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.27B | -USD 245.03M | -USD 245.36M | 62.7% | n/a | USD 604.79M | USD 1.33B | USD 491.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 10.84B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Tempus AI
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tempus AI's market cap?
Tempus AI's market capitalization is EUR 10.84B.
What does Tempus AI do?
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.